Pet allergies significantly affect the bond between humans and their pets, causing discomfort for many. In Canada, over 30% of the population, or more than 11.4 million people, are allergic to pet dander. Symptoms such as itchy skin, rashes, watery eyes, and sneezing can make living with pets challenging.
Read More
Researchers in Japan are making progress toward a viable vaccine to alleviate allergies to dogs. Allergic reactions are common and can occur even in pet owners, originating from various molecules including those found in dander and saliva. While most allergies lead to mild symptoms, an estimated 5-10% of individuals experience severe reactions, including asthma and allergic rhinitis.
Hypoallergenic dog breeds, like Bichon Frise and Labradoodles, are often sought by those allergic to pets. However, no breed is entirely hypoallergenic. These breeds typically produce less dander and saliva, leading to fewer allergic reactions.
Seven specific molecules from dogs are known to trigger allergic reactions in humans. Notably, one molecule accounts for up to 75% of allergic reactions. The research team in Japan is utilizing X-ray Crystallography to isolate portions of this molecule, referred to as epitopes, allowing detailed examination at an atomic level.
The findings have been published in the Federation of European Biochemical Societies Journal. The vaccine aims to expose the immune system to controlled doses of the allergen, training it to reduce or eliminate reactions.
As this promising vaccine progresses, it may pave the way for similar developments for allergies to cats and other pets. Researchers are optimistic that the vaccine will be available to the public in the near future, potentially offering relief to those suffering from dog allergies.
Brandon Forder, known as The Pet Expert, is the vice president of Canadian Pet Connection and has extensive experience in pet health and behavior. He is certified in pet nutrition and has contributed to various media on responsible pet ownership.